The validity of test results depends on the quality and integrity of the samples received, and the preservation of an unbroken chain of custody. As part of our services, we provide in-depth training to our corporate clients to ensure that the specimen collection process supports legally defensible drug testing. This also protects the specimen donors. iMed Laboratories has processes and procedures in place to be followed for receipt, inspection and registration of samples. These measures protect the quality and integrity of the samples, as well as the chain of custody.

We use a comprehensive Laboratory Information Management System (LIMS) that meets HIPAA and FDA guidelines, including 21 requirements from Part 11 of the Code of Federal Regulations (CFR). We adhere to these standards to manage sample collection data and to guide testing processes. This process is fully integrated with the chain of custody and storage location.

At iMed Laboratories, we understand that accurate and reliable turnaround times on drug tests help drive your timely business decisions. We analyze samples and issue test reports within 24 hours of samples being received, provided that all specimen collection, identification, packaging and delivery requirements are followed. Results are reported in nanograms per milliliter and evaluated against cut-off levels that have been established by SAMHSA (U.S. Substance Abuse and Mental Health Services Administration).

If you don’t already have a drug-testing program in place, we can help you design and implement one. iMed’s leg al department advises its corporate clients on policy development. We provide all the necessary screening supplies, and we have built a first-class laboratory to confirm preliminary positive results.